Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions

Effects of other drugs on Imlifidase

2 evidence topics · 2 sources

Drug interactions

“Avoid intravenous immunoglobulins within four weeks and other IgG-based biologics within two weeks before imlifidase because of potential enzyme neutralisation or loss of biologic effect.” (opens the source at this quote in a new tab)

Neutralizing antibodies in intravenous immunoglobulin preparations

“anti-IdeS IgG capable of neutralizing IdeS enzymatic activity in therapeutic preparations of pooled normal human IgG (IVIg).” (opens the source at this quote in a new tab)